Four major drug companies are committing a combined $80 million for a project to address racial inequities in scientific and medical research in partnership with Nashville’s Meharry Medical College. 

Regeneron Pharmaceuticals, AstraZeneca, Novo Nordisk and Roche launched Together for Changing Healthcare for People of African-Ancestry through an InterNational Genomics & Equity (Together for CHANGE) in Nashville on Wednesday.